<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7309305\results\search\drug\results.xml">
  <result pre="molecular dynamics simulation and total binding free energy revealed that" exact="Saquinavir" post="and TCM5280805 target the catalytic dyad (His41 and Cys145)"/>
  <result pre="these compounds should be tested experimentally against the SARS-COV-2 as" exact="Saquinavir" post="has been reported to inhibit HIV protease experimentally. Considering"/>
  <result pre="Barton, 2010). This approach was fruitful in the case of" exact="sildenafil" post="for leprosy, erectile dysfunction, and pulmonary hypertension, and multiple"/>
  <result pre="for leprosy, erectile dysfunction, and pulmonary hypertension, and multiple myeloma" exact="thalidomide" post="(Hernandez et al., 2017). Literature mining was carried out"/>
  <result pre="HIV-1 HIV-II HBV HTLV-1 Enfuvirtide DB00109 âœ&quot; X X X" exact="Nelfinavir" post="DB00220 âœ&quot; X X X Indinavir DB00224 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Indinavir DB00224 âœ&quot; X X âœ&quot;" exact="Nevirapine" post="DB00238 âœ&quot; X X X Tenofovirdisoproxil DB00300 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Tenofovirdisoproxil DB00300 âœ&quot; X X X" exact="Zidovudine" post="DB00495 âœ&quot; X X X Ritonavir DB00503 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Zidovudine DB00495 âœ&quot; X X X" exact="Ritonavir" post="DB00503 âœ&quot; X X X Efavirenz DB00625 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Ritonavir DB00503 âœ&quot; X X X" exact="Efavirenz" post="DB00625 âœ&quot; X X X Stavudine DB00649 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Efavirenz DB00625 âœ&quot; X X X" exact="Stavudine" post="DB00649 âœ&quot; X X X Amprenavir DB00701 âœ&quot; âœ&quot;"/>
  <result pre="âœ&quot; âœ&quot; X X Delavirdine DB00705 âœ&quot; X X X" exact="Lamivudine" post="DB00709 âœ&quot; X âœ&quot; X Emtricitabine DB00879 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Lamivudine DB00709 âœ&quot; X âœ&quot; X" exact="Emtricitabine" post="DB00879 âœ&quot; X X X Didanosine DB00900 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Didanosine DB00900 âœ&quot; X X X" exact="Tipranavir" post="DB00932 âœ&quot; X X X Zalcitabine DB00943 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Tipranavir DB00932 âœ&quot; X X X" exact="Zalcitabine" post="DB00943 âœ&quot; X X X Abacavir DB01048 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Zalcitabine DB00943 âœ&quot; X X X" exact="Abacavir" post="DB01048 âœ&quot; X X X Atazanavir DB01072 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Abacavir DB01048 âœ&quot; X X X" exact="Atazanavir" post="DB01072 âœ&quot; X X X Saquinavir DB01232 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Atazanavir DB01072 âœ&quot; X X X" exact="Saquinavir" post="DB01232 âœ&quot; X X X Darunavir DB01264 âœ&quot; âœ&quot;"/>
  <result pre="âœ&quot; X X X Darunavir DB01264 âœ&quot; âœ&quot; X X" exact="Fosamprenavir" post="DB01319 âœ&quot; X X X Lopinavir DB01601 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Maraviroc DB04835 âœ&quot; X X X" exact="Etravirine" post="DB06414 âœ&quot; X X X Raltegravir DB06817 âœ&quot; X"/>
  <result pre="âœ&quot; X X X Dolutegravir DB08930 âœ&quot; X X X" exact="Cobicistat" post="DB09065 âœ&quot; X X X Elvitegravir DB09101 âœ&quot; X"/>
  <result pre="score âˆ’9.09â€‰kcal/mol was reported for the HIV protease inhibitor drug" exact="Saquinavir" post="(Figure 2). This drug has been reported to inhibit"/>
  <result pre="the HIV proteinase enzymes too. In this case, (SARS-COV-2), the" exact="Saquinavir" post="formed six hydrogen bonds, including two with the central"/>
  <result pre="also formed. Thus, we speculate that the clinical testing of" exact="Saquinavir" post="should be done at the earliest. It is also"/>
  <result pre="used against the recent coronavirus. Figure 2. Interaction pattern of" exact="Saquinavir" post="with the SARS-COV-2 proteinase. The left panes show the"/>
  <result pre="Saquinavir with the SARS-COV-2 proteinase. The left panes show the" exact="Saquinavir" post="drug in 2D, while the right panel shows the"/>
  <result pre="in 2D, while the right panel shows the interaction of" exact="Saquinavir" post="with the critical active site residues, including His41 and"/>
  <result pre="by comparing with the experimentally tested compounds showed that the" exact="Saquinavir" post="and TCM5280805 possess a similar scaffold with Myricetrin and"/>
  <result pre="protease target. From the scores it can be seen that" exact="Saquinavir" post="with score 0.40 possesses strong inhibitory effects against the"/>
  <result pre="against the 3CLpro of SARS-COV-2. Recently published results also shortlisted" exact="Saquinavir" post="as a potential candidate, but they only performed 20â€‰ns"/>
  <result pre="given in Table 3, thus these results strongly suggest that" exact="Saquinavir" post="and TCM5280805 should be tested experimentally against the SARS-COV-2"/>
  <result pre="of the entire article stressed the potential inhibitory role of" exact="Saquinavir" post="and TCM5280805, which are based on computer-based virtual drug"/>
  <result pre="addition, the bioactivity of these compounds were predicted which reported" exact="Saquinavir" post="as strong potential inhibitor followed by the others.Binding Free"/>
  <result pre="receptor. Thus, here from all the analyses, we suggest that" exact="Saquinavir" post="and TCM5280805 should be tested experimentally for possible treatment"/>
  <result pre="AlmakhlafiG. A., AlbarrakM. M., MemishZ. A., &amp;amp; AlbarrakA. M. (2014)." exact="Ribavirin" post="and interferon alfa-2a for severe Middle East respiratory syndrome"/>
 </snippets>
</snippetsTree>
